Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Treatment of psoriasis. Part 2. Systemic therapies
Mark Lebwohl
, Suad Ali
Research output
:
Contribution to journal
›
Article
›
peer-review
205
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of psoriasis. Part 2. Systemic therapies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Systemic Therapy
100%
Psoriasis Treatment
100%
Systemic Medications
66%
United States
33%
Cyclosporine
33%
Tacrolimus
33%
Methotrexate
33%
Retinoids
33%
Mycophenolate Mofetil
33%
Hydroxyurea
33%
6-Thioguanine (6-TG)
33%
Investigational Therapies
33%
Dosage Recommendations
33%
Sulfasalazine
33%
Medicine and Dentistry
Psoriasis
100%
Systemic Therapy
100%
Drug Therapy
66%
Cyclosporine
33%
Tacrolimus
33%
Methotrexate
33%
Hydroxyurea
33%
Retinoid
33%
Experimental Therapy
33%
Tioguanine
33%
Salazosulfapyridine
33%
Mycophenolate Mofetil
33%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriasis
100%
Methotrexate
33%
Ciclosporin
33%
Tacrolimus
33%
Hydroxycarbamide
33%
Retinoid
33%
Tioguanine
33%
Sulfasalazine
33%
Mycophenolate Mofetil
33%